ZIM Laboratories (NSE:ZIMLAB, BOM:541400) consolidated profit attributable to the owners dropped to 37.4 million Indian rupees in the fiscal fourth quarter from 48.8 million rupees a year ago, according to an Indian bourse filing on Tuesday.
Shares of the company fell over 4% in Wednesday's trade.
Earnings per share for the quarter ended March 31 contracted to 0.76 rupees from 1.01 rupees a year earlier.
The pharmaceutical company's revenue from operations also slipped year on year to 1.05 billion rupees from 1.09 billion rupees, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.